Through the 90-day period concluding January 09, 2026, Foghorn Therapeutics's top three insider stakeholders include Chief Executive Officer Adrian Gottschalk (511.70K shares), Chief Scientific Officer Carl Decicco (362.71K shares), Director Cigall Kadoch (295.00K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Adrian Gottschalk | Chief Executive Officer | 511,704 | 18 Aug, 2023 |
| Carl Decicco | Chief Scientific Officer | 362,707 | 13 Dec, 2021 |
| Cigall Kadoch | 295,000 | 16 Dec, 2021 | |
| Steven F. Bellon | Chief Scientific Officer | 101,957 | 11 Sep, 2024 |
| Fanny Cavalie | Chief Strategy/Bus Ops Officer | 75,992 | 12 Mar, 2024 |
| Allan Reine | Chief Financial Officer | 53,784 | 11 Aug, 2021 |
| Simba Gill | 34,061 | 14 Sep, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 25 Apr, 2025 | Adrian Gottschalk | Common Stock | D | 300,000 | $0.00 | 511,704 | I | G |
| 25 Apr, 2025 | Adrian Gottschalk | Common Stock | A | 300,000 | $0.00 | 511,704 | I | G |
| 09 Apr, 2025 | Adrian Gottschalk | Common Stock | A | 197,906 | $0.00 | 511,704 | I | G |
| 09 Apr, 2025 | Adrian Gottschalk | Common Stock | D | 197,906 | $0.00 | 511,704 | I | G |
| 23 Sep, 2024 | Carlos Costa | Common Stock | D | 857 | $10.17 | 0 | D | S |
| 23 Sep, 2024 | Carlos Costa | Common Stock | A | 857 | $3.72 | 857 | D | M |
| 20 Sep, 2024 | Carlos Costa | Common Stock | A | 35,756 | $3.72 | 35,756 | D | M |
| 20 Sep, 2024 | Carlos Costa | Common Stock | D | 35,756 | $10.04 | 0 | D | S |
| 18 Sep, 2024 | Carlos Costa | Common Stock | A | 11,574 | $3.72 | 11,574 | D | M |
| 18 Sep, 2024 | Carlos Costa | Common Stock | D | 11,574 | $10.05 | 0 | D | S |
| 17 Sep, 2024 | Carlos Costa | - | - | 0 | D | |||
| 17 Sep, 2024 | Carlos Costa | Common Stock | A | 10,272 | $3.72 | 10,272 | D | M |
| 17 Sep, 2024 | Carlos Costa | - | - | 10,272 | D | |||
| 17 Sep, 2024 | Carlos Costa | Common Stock | D | 10,272 | $10.04 | 0 | D | S |
| 16 Sep, 2024 | Carlos Costa | - | - | 400 | D | |||
| 16 Sep, 2024 | Carlos Costa | Common Stock | D | 400 | $10.00 | 0 | D | S |
| 16 Sep, 2024 | Carlos Costa | Common Stock | A | 400 | $3.72 | 400 | D | M |
| 16 Sep, 2024 | Carlos Costa | - | - | 0 | D | |||
| 09 Sep, 2024 | Steven F. Bellon | Common Stock | D | 20,000 | $9.50 | 101,957 | D | S |
| 09 Sep, 2024 | Steven F. Bellon | - | - | 101,957 | D |